Sclerostin: an Emerging Target for the Treatment of Cancer-Induced Bone Disease

  1. Inicio
  2. »
  3. Sin categoría
  4. »
  5. Sclerostin: an Emerging Target for the Treatment of Cancer-Induced Bone...
Patrocinadores de la web
Lilly
Laboratorios Rubió
Grupo Italfármaco
UCB-Pharma
Theramex
Stada
Gedeon Richter
Kyowa Kirin
Amgen
Gebro
Meiji Pharma
Faes Farma